Litcius/Paper detail

Incidence of suboptimal response to tumor necrosis factor antagonist therapy in inflammatory bowel disease in newly industrialised countries: The EXPLORE study

Jesús K. Yamamoto‐Furusho, Othman Al Harbi, Alessandro Armuzzi, Webber Chan, Enrique Ponce de León, Jiaming Qian, М. В. Шапина, Murat Törüner, Chia–Hung Tu, Byong Duk Ye, Morgane Guennec, Cecilia Sison, Dirk Demuth, Olga Fadeeva, Qasim Khan

2020Digestive and Liver Disease20 citationsDOIOpen Access PDF

Topics & Concepts

Incidence (geometry)MedicineInflammatory bowel diseaseTumor necrosis factor alphaDiseaseInternal medicineTumor necrosis factor αAntagonistGastroenterologyNecrosisImmunologyReceptorOpticsPhysicsInflammatory Bowel DiseaseBiosimilars and Bioanalytical MethodsClostridium difficile and Clostridium perfringens research
Incidence of suboptimal response to tumor necrosis factor antagonist therapy in inflammatory bowel disease in newly industrialised countries: The EXPLORE study | Litcius